# Synlogic Provides Corporate Update and Outlook for 2024
Canonical URL: https://biopharmsignal.com/news/SYBX/synlogic-provides-corporate-update-and-outlook-for-2024
Ticker: SYBX
Company: Synlogic
Source: Synlogic
Published: 2024-01-04 12:00 EST
Original Source URL: https://investor.synlogictx.com
## Summary

- Data review from pivotal Synpheny-3 study in PKU expected in H1 2024, with potential to expand study population to patients aged 12-17 years of age - - Top-line, Phase 3 data in PKU expected in H1 2025 - CAMBRIDGE, Mass. , Jan. 04, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc.

## Article Body
- Data review from pivotal Synpheny-3 study in PKU expected in H1 2024, with potential to expand study population to patients aged 12-17 years of age - - Top-line, Phase 3 data in PKU expected in H1 2025 - CAMBRIDGE, Mass. , Jan. 04, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc.
## Recent Company News
- 2024-11-12 21:35 EST — [Synlogic Reports Third Quarter 2024 Financial Results](https://biopharmsignal.com/news/SYBX/synlogic-reports-third-quarter-2024-financial-results) — Source: Synlogic
- 2024-08-08 11:00 EST — [Synlogic Reports Second Quarter 2024 Financial Results](https://biopharmsignal.com/news/SYBX/synlogic-reports-second-quarter-2024-financial-results) — Source: Synlogic
- 2024-05-14 11:00 EST — [Synlogic Reports First Quarter 2024 Financial Results](https://biopharmsignal.com/news/SYBX/synlogic-reports-first-quarter-2024-financial-results) — Source: Synlogic
- 2024-03-19 11:00 EST — [Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results](https://biopharmsignal.com/news/SYBX/synlogic-reports-fourth-quarter-and-full-year-2023-financial-results) — Source: Synlogic
- 2024-02-20 17:15 EST — [Synlogic Adopts Limited Duration Stockholders Rights Plan](https://biopharmsignal.com/news/SYBX/synlogic-adopts-limited-duration-stockholders-rights-plan) — Source: Synlogic
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)